QA: Corcept Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001088856_2018_Corcept_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001088856, Corcept Therapeutics INC

  xvar xval
0 AssetsCurrent 124,185,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 518,000
3 remainder_Assets 95,834,000
4 LiabilitiesCurrent 29,569,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 57,202,349
9 ResearchAndDevelopmentExpense 34,558,161
10 remainder_Expenses 3,117,655
11 remainder_Revenues 548,421,018
12 remainder_NetIncome -49,000
13 remainder_ComprehensiveNetIncome -75,000
  yvar yval
0 Assets 220,537,000
1 Liabilities 29,569,000
2 Expenses 94,878,165
3 Revenues 548,421,018
4 StockholdersEquity 190,968,000
5 NetIncome 453,493,853
6 ComprehensiveNetIncome 453,456,353
7 BaseVar 446,764,592
8 EconomicCapitalRatiobeforeLimitedLiability 6.96
9 EconomicCapitalRatio 6.98

Edgar->Model Mapping

Feature Distribution

Change over Time